Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 10 | $51,242,890 |
| Sells | 206 | $99,197,667 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 21 Mar 2025 18:30 | SPRY | ARS Pharmaceuticals Inc | KARAS ERIC | Chief Commercial Officer | 20 Mar 2025 | Sale | 10,000 | 14 | 140,000 | D |
| 07 Mar 2025 17:12 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 05 Mar 2025 | Sale | 400 | 11 | 4,400 | D |
| 07 Mar 2025 17:12 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 06 Mar 2025 | Sale | 49,600 | 11.2106 | 556,046 | D |
| 04 Feb 2025 16:35 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 03 Feb 2025 | Sale | 50,000 | 12.3113 | 615,565 | D |
| 07 Jan 2025 18:24 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 06 Jan 2025 | Sale | 50,000 | 11.1013 | 555,065 | D |
| 19 Dec 2024 16:20 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 17 Dec 2024 | Sale | 50,000 | 11.6715 | 583,575 | I |
| 19 Dec 2024 16:20 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 17 Dec 2024 | Sale | 50,000 | 11.6705 | 583,525 | I |
| 19 Dec 2024 16:20 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 17 Dec 2024 | Sale | 50,000 | 11.6715 | 583,575 | I |
| 19 Dec 2024 16:20 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 17 Dec 2024 | Sale | 50,000 | 11.6705 | 583,525 | I |
| 13 Dec 2024 19:53 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 12 Dec 2024 | Sale | 117,333 | 12.2653 | 1,439,124 | D |
| 13 Dec 2024 19:53 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 13 Dec 2024 | Sale | 27,272 | 12.0625 | 328,968 | D |
| 13 Dec 2024 19:52 | SPRY | ARS Pharmaceuticals Inc | DORSEY BRIAN | Chief Operating Officer | 11 Dec 2024 | Sale | 15,000 | 12.4284 | 186,426 | D |
| 13 Dec 2024 19:52 | SPRY | ARS Pharmaceuticals Inc | DORSEY BRIAN | Chief Operating Officer | 12 Dec 2024 | Sale | 25,000 | 12.2973 | 307,432 | D |
| 12 Dec 2024 17:41 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 10 Dec 2024 | Sale | 50,000 | 13.1525 | 657,625 | D |
| 11 Dec 2024 18:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 10 Dec 2024 | Sale | 50,000 | 13.1653 | 658,265 | I |
| 11 Dec 2024 18:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 10 Dec 2024 | Sale | 50,000 | 13.1631 | 658,155 | I |
| 11 Dec 2024 18:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 10 Dec 2024 | Sale | 50,000 | 13.1653 | 658,265 | I |
| 11 Dec 2024 18:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 10 Dec 2024 | Sale | 50,000 | 13.1631 | 658,155 | I |
| 06 Dec 2024 19:15 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 04 Dec 2024 | Sale | 45,000 | 13.9543 | 627,944 | D |
| 06 Dec 2024 19:15 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 05 Dec 2024 | Sale | 49,640 | 14.1346 | 701,642 | D |
| 06 Dec 2024 19:15 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 06 Dec 2024 | Sale | 50,000 | 14.2323 | 711,615 | D |
| 04 Dec 2024 21:45 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 02 Dec 2024 | Sale | 45,000 | 13.6715 | 615,218 | D |
| 04 Dec 2024 21:45 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 03 Dec 2024 | Sale | 45,000 | 13.1867 | 593,402 | D |
| 04 Dec 2024 21:40 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 02 Dec 2024 | Sale | 96,343 | 13.5539 | 1,305,823 | D |
| 04 Dec 2024 21:40 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 02 Dec 2024 | Sale | 901 | 14.3417 | 12,922 | D |
| 04 Dec 2024 21:40 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 03 Dec 2024 | Sale | 87,984 | 13.2626 | 1,166,897 | D |
| 04 Dec 2024 21:40 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 04 Dec 2024 | Sale | 14,772 | 13.7496 | 203,109 | D |
| 04 Dec 2024 21:40 | SPRY | ARS Pharmaceuticals Inc | KARAS ERIC | Chief Commercial Officer | 02 Dec 2024 | Sale | 3,717 | 14.1139 | 52,461 | D |
| 04 Dec 2024 21:40 | SPRY | ARS Pharmaceuticals Inc | KARAS ERIC | Chief Commercial Officer | 04 Dec 2024 | Sale | 6,283 | 14 | 87,962 | D |
| 27 Nov 2024 16:11 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 25 Nov 2024 | Sale | 32,814 | 14.0008 | 459,422 | D |
| 27 Nov 2024 16:11 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 26 Nov 2024 | Sale | 42,186 | 14.0466 | 592,570 | D |
| 27 Nov 2024 16:11 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 27 Nov 2024 | Sale | 25,000 | 14.39 | 359,750 | D |
| 21 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 19 Nov 2024 | Sale | 50,000 | 13.9502 | 697,510 | I |
| 21 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 19 Nov 2024 | Sale | 50,000 | 13.949 | 697,450 | I |
| 21 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 19 Nov 2024 | Sale | 50,000 | 13.9502 | 697,510 | I |
| 21 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 19 Nov 2024 | Sale | 50,000 | 13.949 | 697,450 | I |
| 14 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 12 Nov 2024 | Sale | 45,045 | 16.7589 | 754,905 | I |
| 14 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 12 Nov 2024 | Sale | 4,955 | 17.643 | 87,421 | I |
| 14 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 12 Nov 2024 | Sale | 45,124 | 16.7604 | 756,296 | I |
| 14 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 12 Nov 2024 | Sale | 4,876 | 17.6416 | 86,020 | I |
| 14 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 12 Nov 2024 | Sale | 45,045 | 16.7589 | 754,905 | I |
| 14 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 12 Nov 2024 | Sale | 4,955 | 17.643 | 87,421 | I |
| 14 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 12 Nov 2024 | Sale | 45,124 | 16.7604 | 756,296 | I |
| 14 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 12 Nov 2024 | Sale | 4,876 | 17.6416 | 86,020 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 11 Nov 2024 | Sale | 40,596 | 17.45 | 708,400 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 11 Nov 2024 | Sale | 40,596 | 17.45 | 708,400 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 11 Nov 2024 | Sale | 223,632 | 18.15 | 4,058,921 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 11 Nov 2024 | Sale | 223,632 | 18.15 | 4,058,921 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 12 Nov 2024 | Sale | 7,853 | 17.16 | 134,757 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 12 Nov 2024 | Sale | 7,854 | 17.16 | 134,775 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 12 Nov 2024 | Sale | 9,554 | 17.77 | 169,775 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 12 Nov 2024 | Sale | 9,553 | 17.77 | 169,757 | I |
| 17 Oct 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | SCOTT KATHLEEN D. | Chief Financial Officer | 16 Oct 2024 | Sale | 12,500 | 16 | 200,000 | D |
| 17 Oct 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 15 Oct 2024 | Sale | 48,550 | 14.8642 | 721,657 | I |
| 17 Oct 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 15 Oct 2024 | Sale | 1,450 | 15.2539 | 22,118 | I |
| 17 Oct 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 15 Oct 2024 | Sale | 50,000 | 14.8764 | 743,820 | I |
| 17 Oct 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 15 Oct 2024 | Sale | 48,550 | 14.8642 | 721,657 | I |
| 17 Oct 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 15 Oct 2024 | Sale | 1,450 | 15.2539 | 22,118 | I |
| 17 Oct 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 15 Oct 2024 | Sale | 50,000 | 14.8764 | 743,820 | I |
| 10 Oct 2024 16:28 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 08 Oct 2024 | Sale | 50,000 | 13.8277 | 691,385 | I |
| 10 Oct 2024 16:28 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 08 Oct 2024 | Sale | 50,000 | 13.8278 | 691,390 | I |
| 10 Oct 2024 16:27 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 08 Oct 2024 | Sale | 50,000 | 13.8277 | 691,385 | I |
| 10 Oct 2024 16:27 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 08 Oct 2024 | Sale | 50,000 | 13.8278 | 691,390 | I |
| 19 Sep 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | KARAS ERIC | Chief Commercial Officer | 18 Sep 2024 | Sale | 10,000 | 14 | 140,000 | D |
| 19 Sep 2024 16:29 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 17 Sep 2024 | Sale | 50,000 | 12.9336 | 646,680 | I |
| 19 Sep 2024 16:29 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 17 Sep 2024 | Sale | 50,000 | 12.9305 | 646,525 | I |
| 19 Sep 2024 16:26 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 17 Sep 2024 | Sale | 50,000 | 12.9336 | 646,680 | I |
| 19 Sep 2024 16:26 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 17 Sep 2024 | Sale | 50,000 | 12.9305 | 646,525 | I |
| 12 Sep 2024 16:25 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 10 Sep 2024 | Sale | 50,000 | 11.4982 | 574,910 | I |
| 12 Sep 2024 16:25 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 10 Sep 2024 | Sale | 50,000 | 11.4973 | 574,865 | I |
| 12 Sep 2024 16:24 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 10 Sep 2024 | Sale | 50,000 | 11.4973 | 574,865 | I |
| 12 Sep 2024 16:24 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 10 Sep 2024 | Sale | 50,000 | 11.4982 | 574,910 | I |
| 28 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 26 Aug 2024 | Sale | 83,695 | 13 | 1,088,035 | I |
| 28 Aug 2024 16:26 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 26 Aug 2024 | Sale | 83,695 | 13 | 1,088,035 | I |
| 23 Aug 2024 18:41 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 23 Aug 2024 | Sale | 69,500 | 13.03 | 905,585 | I |
| 23 Aug 2024 18:41 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 22 Aug 2024 | Sale | 391,482 | 12.94 | 5,065,777 | I |
| 23 Aug 2024 18:41 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 21 Aug 2024 | Sale | 13,300 | 14.61 | 194,313 | I |
| 23 Aug 2024 18:41 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 21 Aug 2024 | Sale | 394,400 | 13.52 | 5,332,288 | I |
| 23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 23 Aug 2024 | Sale | 69,500 | 13.03 | 905,585 | I |
| 23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 22 Aug 2024 | Sale | 391,482 | 12.94 | 5,065,777 | I |
| 23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 21 Aug 2024 | Sale | 13,300 | 14.61 | 194,313 | I |
| 23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 21 Aug 2024 | Sale | 394,400 | 13.52 | 5,332,288 | I |
| 21 Aug 2024 18:51 | SPRY | ARS Pharmaceuticals Inc | DORSEY BRIAN | Chief Operating Officer | 20 Aug 2024 | Sale | 50,000 | 15 | 750,000 | D |
| 21 Aug 2024 18:51 | SPRY | ARS Pharmaceuticals Inc | KARAS ERIC | Chief Commercial Officer | 19 Aug 2024 | Sale | 10,000 | 14 | 140,000 | D |
| 21 Aug 2024 18:49 | SPRY | ARS Pharmaceuticals Inc | SCOTT KATHLEEN D. | Chief Financial Officer | 20 Aug 2024 | Sale | 12,500 | 16 | 200,000 | D |
| 21 Aug 2024 18:48 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 20 Aug 2024 | Sale | 2,261 | 16.2532 | 36,748 | I |
| 21 Aug 2024 18:48 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 20 Aug 2024 | Sale | 11,523 | 15.6234 | 180,028 | I |
| 21 Aug 2024 18:48 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 20 Aug 2024 | Sale | 36,216 | 14.7576 | 534,461 | I |
| 21 Aug 2024 18:48 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 20 Aug 2024 | Sale | 2,300 | 16.2589 | 37,395 | I |
| 21 Aug 2024 18:48 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 20 Aug 2024 | Sale | 11,756 | 15.6129 | 183,545 | I |
| 21 Aug 2024 18:48 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 20 Aug 2024 | Sale | 35,944 | 14.7565 | 530,408 | I |
| 21 Aug 2024 18:47 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 20 Aug 2024 | Sale | 2,261 | 16.2532 | 36,748 | I |
| 21 Aug 2024 18:47 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 20 Aug 2024 | Sale | 11,523 | 15.6234 | 180,028 | I |
| 21 Aug 2024 18:47 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 20 Aug 2024 | Sale | 36,216 | 14.7576 | 534,461 | I |
| 21 Aug 2024 18:47 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 20 Aug 2024 | Sale | 2,300 | 16.2589 | 37,395 | I |
| 21 Aug 2024 18:47 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 20 Aug 2024 | Sale | 11,756 | 15.6129 | 183,545 | I |
| 21 Aug 2024 18:47 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 20 Aug 2024 | Sale | 35,944 | 14.7565 | 530,408 | I |
| 15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | DORSEY BRIAN | Chief Operating Officer | 13 Aug 2024 | Sale | 30,000 | 13 | 390,000 | D |
| 15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 13 Aug 2024 | Sale | 35,363 | 12.7659 | 451,441 | I |
| 15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 13 Aug 2024 | Sale | 14,637 | 11.7734 | 172,327 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)